Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.300
-0.040 (-0.92%)
At close: Dec 27, 2024, 4:00 PM
4.280
-0.020 (-0.47%)
After-hours: Dec 27, 2024, 4:58 PM EST
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 81.12M CAD in the quarter ending September 30, 2024, with 28.52% growth. This brings the company's revenue in the last twelve months to 296.99M, up 13.15% year-over-year. In the fiscal year ending March 31, 2024, Aurora Cannabis had annual revenue of 270.28M with 20.77% growth.
Revenue (ttm)
296.99M CAD
Revenue Growth
+13.15%
P/S Ratio
n/a
Revenue / Employee
276,782 CAD
Employees
1,073
Market Cap
236.30M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 270.28M | 46.48M | 20.77% |
Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
Jun 30, 2020 | 268.70M | 23.17M | 9.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LifeMD | 193.06M |
Anika Therapeutics | 164.17M |
Heron Therapeutics | 137.74M |
SOPHiA GENETICS | 64.49M |
BGM Group | 29.87M |
Ocugen | 4.70M |
ACB News
- 18 hours ago - Cannabis sector limps into 2025 because ‘the gold rush is over' - Market Watch
- 1 day ago - 2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now - MarijuanaStocks
- 10 days ago - Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect - PRNewsWire
- 4 weeks ago - Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities - Benzinga
- 4 weeks ago - Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility - PRNewsWire
- 5 weeks ago - Marijuana Industry Could Stay in Limbo Under Trump - WSJ
- 5 weeks ago - Aurora Cannabis Expands Innovative Recreational Product Portfolio - PRNewsWire
- 5 weeks ago - Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha